AAPG
Ascentage Pharma Group International Co., Ltd.
NASDAQ · Healthcare · Biotechnology · CN
$15.06
−2.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.96x
- Price / sales
- 14.91x
- Price / cash flow
- -6.84x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 15.24x
- EV / EBITDA
- -7.42x
- EV / EBIT
- -6.97x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026